Evidence map›Paper›PMID 40777374›Full record

ArticlebioRxiv : the preprint server for biology2025

mGluR4-Npdc1 complex mediates α-synuclein fibril-induced neurodegeneration.

Azucena Perez-Canamas, Mingming Chen, Leire Almandoz-Gil, Nabab Khan, Si Jie Tang, Allyson Ho, Erik C Gunther, Stephen M Strittmatter

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Azucena Perez-CanamasDepartments of Neuroscience and Neurology, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale School of Medicine, 100 College Street, New Haven, CT 06510 USA.
Mingming ChenDepartments of Neuroscience and Neurology, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale School of Medicine, 100 College Street, New Haven, CT 06510 USA.
Leire Almandoz-GilDepartments of Neuroscience and Neurology, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale School of Medicine, 100 College Street, New Haven, CT 06510 USA.
Nabab KhanDepartments of Neuroscience and Neurology, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale School of Medicine, 100 College Street, New Haven, CT 06510 USA.
Si Jie TangDepartments of Neuroscience and Neurology, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale School of Medicine, 100 College Street, New Haven, CT 06510 USA.
Allyson HoDepartments of Neuroscience and Neurology, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale School of Medicine, 100 College Street, New Haven, CT 06510 USA.
Erik C GuntherDepartments of Neuroscience and Neurology, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale School of Medicine, 100 College Street, New Haven, CT 06510 USA.
Stephen M StrittmatterDepartments of Neuroscience and Neurology, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale School of Medicine, 100 College Street, New Haven, CT 06510 USA.ORCID 0000-0001-8188-3092

Funding

Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER, CHRISTOPHER H VAN DYCK · 2020 to 2026
$30.2M
Prion Protein in Alzheimer's Disease PathophysiologyR01AG034924 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2010 to 2026
$9.6M
Genome-Wide Discovery and Translational Research for Neural RepairR35NS097283 · NINDS · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2017 to 2024
$8.1M
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDPR01AG066165 · NIA · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2019 to 2023
$3.9M
Synaptic selectivity for microglial-mediated damage in Alzheimer's DiseaseR01AG070926 · NIA · YALE UNIVERSITY · PI STRITTMATTER, STEPHEN M · 2024 to 2025
$1.6M
NIA NIH HHS P30 AG066508NIA NIH HHS R01 AG034924NIA NIH HHS R01 AG066165NIA NIH HHS R01 AG070926NINDS NIH HHS R35 NS097283
6 · The paper itself

Abstract

Fibrils of misfolded α-synuclein (α-syn) accumulate in Parkinson's disease and other synucleinopathies, spreading between cells to template further misfolding and drive neurodegeneration. α-syn fibril entry into healthy neurons is recognized as a key step in the disease process but remains ill-defined mechanistically. Here, we comprehensively assessed the membrane proteome for binding of α-syn fibrils. Expression cloning identified mGluR4 and Npdc1 as plasma membrane proteins expressed by substantia nigra neurons capable of supporting high affinity α-syn fibril binding. Moreover, mGluR4 and Npdc1 cellular signaling functions were titrated by the presence of extracellular fibrillary α-syn. While striatal α-syn fibril injection led to nigral dopamine neuron loss in wild type mice, deletion of either

Identifiers

PMID40777374
PMCPMC12330738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.